Momenta Isn't Shielded From Antitrust Suit, 1st Circ. Says

By Cara Bayles (March 6, 2017, 10:40 PM EST) -- The First Circuit on Monday revived an antitrust suit alleging Momenta Inc. and Sandoz Inc. misled regulators about their patent on the industry test for an anticoagulant so they could squeeze rival Amphastar Pharmaceuticals Inc. out of the market with infringement claims, finding the district court erroneously applied the Noerr-Pennington doctrine....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!